MedPath

Erythropoietin Gel Effect on Dental Implant Stability

Not Applicable
Not yet recruiting
Conditions
Osseointegration
Registration Number
NCT06665451
Lead Sponsor
Al-Azhar University
Brief Summary

* Achieving and maintaining long-term osseointegration for dental implants is a key objective in the field of dentistry. The success of osseointegration is influenced by the surface treatment applied to dental implants. Numerous coating techniques have been developed to improve and speed up osseointegration.

* The aim of the current study is to assess immediate dental implant stability coated with erythropoietin gel, both clinically and radiographically.

* Materials and Methods: We conducted a randomized controlled clinical trial.The sample will include patients demanding immediate implant treatment in the anterior maxilla . Patients will be randomly allocated into the two groups of the study. The group A will be treated with erythropoietin gel coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . Group B will be treated with non coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla .

* The primary outcome variable will be implant stability and the secondary outcome will be crestal marginal bone level and bone density around implants. It will be measured at time of implant placement and reevaluated after 6-months .

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • All patients Should have nonrestorable teeth in the anterior maxilla indicated for extraction and seeking implant placement.
  • Good general periodontal health and maintenance.
Exclusion Criteria
  • Heavy smokers who smoke more than ten cigarettes per day
  • Acute infected socket
  • Ant socket with wall defect.
  • Pregnency
  • Local or systemic conditions that will interfere with bone healing (uncontrolled diabetes mellitus or human immune deficiency virus infections, resonance therapy), bone disorders (hyperparathyroidism, osteoporosis, or Paget's disease.
  • Patients who had subjected to intravenous and/or oral bisphosphonate therapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in implant stabilityBaseline and after 6 month

Implant stability will be assessed by using ( AnyCheck - Implant Stability Tester ) Utilizes physical tapping technique and dumping capacity analysis to measure implant stability with precision

Secondary Outcome Measures
NameTimeMethod
Change in marginal bone level and bone density around implantsBaseline and after 6 month

To evaluate the amount of marginal bone loss and bone density around osseointegrated implants, all patient will be subjected to Cone beam computed tomography (CBCT) immediate postoperative and after 6 months.

Trial Locations

Locations (1)

Faculty of dental medicine Al-Azhar university

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath